Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia

By Ganesan S.   Agambaram V.   Randeree F.   Eggens I.   Huizar K.   Meulien D.    

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 21-32

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents

By Kim Eun Young   Chang Sung Man   Shim Joo Cheol   Joo Eun Jeong   Kim Jae Jin   Kim Yong Sik   Ahn Yong Min  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1231-1240

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

By Imanaka Keiichiro   Tominaga Yushin   Etropolski Mila   van Hove Ilse   Ohsaka Masaki   Wanibe Mikio   Hirose Keiichiro   Matsumura Taka  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1399-1409

Informa Healthcare

Access to resources Recommend Favorite

Switching from Epoetin Alpha to Darbepoetin Alpha in Japanese Hemodialysis Patients: Dose Conversion Ratio

By  

Nephron Clin Pract, Vol. 111, Iss. 2, 2008-12 ,pp. : c81-c86

Karger

Access to resources Recommend Favorite

Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion

By Arnold L.E.   Bozzolo D.R.   Hodgkins P.   McKay M.   Beckett-Thurman L.   Greenbaum M.   Bukstein O.   Patel A.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 129-137

Informa Healthcare

Access to resources Recommend Favorite